Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvement
Open Access
- 1 March 2019
- journal article
- editorial
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 7 (S1) , S18
Abstract
Revisiting AJCC TNM staging for renal cell carcinoma: quest for improvementKeywords
This publication has 17 references indexed in Scilit:
- External validation of clinical prediction models using big datasets from e-health records or IPD meta-analysis: opportunities and challengesBMJ, 2016
- American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicineCA: A Cancer Journal for Clinicians, 2016
- Editorial CommentJournal of Urology, 2011
- Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary ReviewEuropean Urology, 2011
- The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinomaCancer, 2011
- TNM Staging for Renal Cell Carcinoma: Time for a New MethodEuropean Urology, 2010
- Molecular Signatures of Localized Clear Cell Renal Cell Carcinoma to Predict Disease-Free Survival after NephrectomyCancer Epidemiology, Biomarkers & Prevention, 2009
- Genomic advances and their impact on clinical trial designGenome Medicine, 2009
- Bias as a threat to the validity of cancer molecular-marker researchNature Reviews Cancer, 2005
- Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimationStatistics in Medicine, 2004